Drugsampling.com, a computer controlled system that monitors the distribution of drug samples, is being tested in Boston's Lahey Clinic.
Drugsampling.com, a computer controlled system that monitors the distribution of drug samples, is being tested in Boston's Lahey Clinic.
"Insufficient control [of drug samples] can endanger patients and staff and clearly violates accreditation standards and regulatory statutes," said Ernie Anderson, director of pharmacy at Lahey Clinic. "It also contributes to higher drug costs and makes it difficult for pharmaceutical companies to obtain credible sampling data."
The Drugsampling.com system, which was developed by the Lahey Clinic with the help of ADDS Inc., North Billerica, MA, includes computer-controlled dispensing cabinets that hold a wide range of samples. The cabinets can only be opened by authorized medical staff who are identified through fingerprint-recognition technology.
Once opened, the cabinet contains a touch screen computer that enables physicians to input their name, patient name and drug to be sampled. The system then prints out educational material and labels for the patient in accordance with all Joint Commission on Accreditation of Healthcare Organizations standards while documenting transactions completely.
Currently, Lahey Clinic has the new systems working with 12 clinics and plans to add 12 more before expanding to 44 regional clinics. PR
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.